世界の胆嚢がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gallbladder Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4239 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、胆嚢がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メシル酸アパチニブ、BGBA-317、ビニメチニブ、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胆嚢がん治療の市場動向 ・企業の競争状況、市場シェア ・胆嚢がん治療の種類別市場規模と予測2016-2027（メシル酸アパチニブ、BGBA-317、ビニメチニブ、その他） ・胆嚢がん治療の用途別市場規模と予測2016-2027（クリニック、病院、その他） ・胆嚢がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・胆嚢がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆嚢がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆嚢がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆嚢がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（4SC AG、Advenchen Laboratories LLC、Array BioPharma Inc、Aslan Pharmaceuticals Pte Ltd、Bayer AG、BeiGene Ltd、Eli Lilly and Co、Halozyme Therapeutics Inc、Hutchison MediPharma Ltd、Ipsen SA、Kringle Pharma Inc、Leap Therapeutics Inc、MedImmune LLC、Molecular Templates Inc、Novartis AG、NuCana Plc、OncoTherapy Science Inc、VasGene Therapeutics Inc） ・結論

Market Analysis and Insights: Global Gallbladder Cancer Treatment Market
The global Gallbladder Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gallbladder Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gallbladder Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gallbladder Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gallbladder Cancer Treatment market.

Global Gallbladder Cancer Treatment Scope and Market Size
Gallbladder Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gallbladder Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Apatinib Mesylate
BGBA-317
Binimetinib
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
4SC AG
Advenchen Laboratories LLC
Array BioPharma Inc
Aslan Pharmaceuticals Pte Ltd
Bayer AG
BeiGene Ltd
Eli Lilly and Co
Halozyme Therapeutics Inc
Hutchison MediPharma Ltd
Ipsen SA
Kringle Pharma Inc
Leap Therapeutics Inc
MedImmune LLC
Molecular Templates Inc
Novartis AG
NuCana Plc
OncoTherapy Science Inc
VasGene Therapeutics Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gallbladder Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Apatinib Mesylate
1.2.3 BGBA-317
1.2.4 Binimetinib
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gallbladder Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gallbladder Cancer Treatment Market Perspective (2016-2027)
2.2 Gallbladder Cancer Treatment Growth Trends by Regions
2.2.1 Gallbladder Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gallbladder Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Gallbladder Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Gallbladder Cancer Treatment Industry Dynamic
2.3.1 Gallbladder Cancer Treatment Market Trends
2.3.2 Gallbladder Cancer Treatment Market Drivers
2.3.3 Gallbladder Cancer Treatment Market Challenges
2.3.4 Gallbladder Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gallbladder Cancer Treatment Players by Revenue
3.1.1 Global Top Gallbladder Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Gallbladder Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Gallbladder Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gallbladder Cancer Treatment Revenue
3.4 Global Gallbladder Cancer Treatment Market Concentration Ratio
3.4.1 Global Gallbladder Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gallbladder Cancer Treatment Revenue in 2020
3.5 Gallbladder Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Gallbladder Cancer Treatment Product Solution and Service
3.7 Date of Enter into Gallbladder Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gallbladder Cancer Treatment Breakdown Data by Type
4.1 Global Gallbladder Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Gallbladder Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Gallbladder Cancer Treatment Breakdown Data by Application
5.1 Global Gallbladder Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Gallbladder Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gallbladder Cancer Treatment Market Size (2016-2027)
6.2 North America Gallbladder Cancer Treatment Market Size by Type
6.2.1 North America Gallbladder Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Gallbladder Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Gallbladder Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Gallbladder Cancer Treatment Market Size by Application
6.3.1 North America Gallbladder Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Gallbladder Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Gallbladder Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Gallbladder Cancer Treatment Market Size by Country
6.4.1 North America Gallbladder Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Gallbladder Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gallbladder Cancer Treatment Market Size (2016-2027)
7.2 Europe Gallbladder Cancer Treatment Market Size by Type
7.2.1 Europe Gallbladder Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Gallbladder Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Gallbladder Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Gallbladder Cancer Treatment Market Size by Application
7.3.1 Europe Gallbladder Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Gallbladder Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Gallbladder Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Gallbladder Cancer Treatment Market Size by Country
7.4.1 Europe Gallbladder Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Gallbladder Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gallbladder Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Gallbladder Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Gallbladder Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gallbladder Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gallbladder Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Gallbladder Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Gallbladder Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gallbladder Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gallbladder Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Gallbladder Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Gallbladder Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gallbladder Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gallbladder Cancer Treatment Market Size (2016-2027)
9.2 Latin America Gallbladder Cancer Treatment Market Size by Type
9.2.1 Latin America Gallbladder Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Gallbladder Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Gallbladder Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Gallbladder Cancer Treatment Market Size by Application
9.3.1 Latin America Gallbladder Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Gallbladder Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Gallbladder Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Gallbladder Cancer Treatment Market Size by Country
9.4.1 Latin America Gallbladder Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Gallbladder Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gallbladder Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Gallbladder Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Gallbladder Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gallbladder Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gallbladder Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Gallbladder Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Gallbladder Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gallbladder Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gallbladder Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Gallbladder Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Gallbladder Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gallbladder Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Gallbladder Cancer Treatment Introduction
11.1.4 4SC AG Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.1.5 4SC AG Recent Development
11.2 Advenchen Laboratories LLC
11.2.1 Advenchen Laboratories LLC Company Details
11.2.2 Advenchen Laboratories LLC Business Overview
11.2.3 Advenchen Laboratories LLC Gallbladder Cancer Treatment Introduction
11.2.4 Advenchen Laboratories LLC Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.2.5 Advenchen Laboratories LLC Recent Development
11.3 Array BioPharma Inc
11.3.1 Array BioPharma Inc Company Details
11.3.2 Array BioPharma Inc Business Overview
11.3.3 Array BioPharma Inc Gallbladder Cancer Treatment Introduction
11.3.4 Array BioPharma Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.3.5 Array BioPharma Inc Recent Development
11.4 Aslan Pharmaceuticals Pte Ltd
11.4.1 Aslan Pharmaceuticals Pte Ltd Company Details
11.4.2 Aslan Pharmaceuticals Pte Ltd Business Overview
11.4.3 Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Introduction
11.4.4 Aslan Pharmaceuticals Pte Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.4.5 Aslan Pharmaceuticals Pte Ltd Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Gallbladder Cancer Treatment Introduction
11.5.4 Bayer AG Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 BeiGene Ltd
11.6.1 BeiGene Ltd Company Details
11.6.2 BeiGene Ltd Business Overview
11.6.3 BeiGene Ltd Gallbladder Cancer Treatment Introduction
11.6.4 BeiGene Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.6.5 BeiGene Ltd Recent Development
11.7 Eli Lilly and Co
11.7.1 Eli Lilly and Co Company Details
11.7.2 Eli Lilly and Co Business Overview
11.7.3 Eli Lilly and Co Gallbladder Cancer Treatment Introduction
11.7.4 Eli Lilly and Co Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.7.5 Eli Lilly and Co Recent Development
11.8 Halozyme Therapeutics Inc
11.8.1 Halozyme Therapeutics Inc Company Details
11.8.2 Halozyme Therapeutics Inc Business Overview
11.8.3 Halozyme Therapeutics Inc Gallbladder Cancer Treatment Introduction
11.8.4 Halozyme Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.8.5 Halozyme Therapeutics Inc Recent Development
11.9 Hutchison MediPharma Ltd
11.9.1 Hutchison MediPharma Ltd Company Details
11.9.2 Hutchison MediPharma Ltd Business Overview
11.9.3 Hutchison MediPharma Ltd Gallbladder Cancer Treatment Introduction
11.9.4 Hutchison MediPharma Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.9.5 Hutchison MediPharma Ltd Recent Development
11.10 Ipsen SA
11.10.1 Ipsen SA Company Details
11.10.2 Ipsen SA Business Overview
11.10.3 Ipsen SA Gallbladder Cancer Treatment Introduction
11.10.4 Ipsen SA Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.10.5 Ipsen SA Recent Development
11.11 Kringle Pharma Inc
11.11.1 Kringle Pharma Inc Company Details
11.11.2 Kringle Pharma Inc Business Overview
11.11.3 Kringle Pharma Inc Gallbladder Cancer Treatment Introduction
11.11.4 Kringle Pharma Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.11.5 Kringle Pharma Inc Recent Development
11.12 Leap Therapeutics Inc
11.12.1 Leap Therapeutics Inc Company Details
11.12.2 Leap Therapeutics Inc Business Overview
11.12.3 Leap Therapeutics Inc Gallbladder Cancer Treatment Introduction
11.12.4 Leap Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.12.5 Leap Therapeutics Inc Recent Development
11.13 MedImmune LLC
11.13.1 MedImmune LLC Company Details
11.13.2 MedImmune LLC Business Overview
11.13.3 MedImmune LLC Gallbladder Cancer Treatment Introduction
11.13.4 MedImmune LLC Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.13.5 MedImmune LLC Recent Development
11.14 Molecular Templates Inc
11.14.1 Molecular Templates Inc Company Details
11.14.2 Molecular Templates Inc Business Overview
11.14.3 Molecular Templates Inc Gallbladder Cancer Treatment Introduction
11.14.4 Molecular Templates Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.14.5 Molecular Templates Inc Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Gallbladder Cancer Treatment Introduction
11.15.4 Novartis AG Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 NuCana Plc
11.16.1 NuCana Plc Company Details
11.16.2 NuCana Plc Business Overview
11.16.3 NuCana Plc Gallbladder Cancer Treatment Introduction
11.16.4 NuCana Plc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.16.5 NuCana Plc Recent Development
11.17 OncoTherapy Science Inc
11.17.1 OncoTherapy Science Inc Company Details
11.17.2 OncoTherapy Science Inc Business Overview
11.17.3 OncoTherapy Science Inc Gallbladder Cancer Treatment Introduction
11.17.4 OncoTherapy Science Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.17.5 OncoTherapy Science Inc Recent Development
11.18 VasGene Therapeutics Inc
11.18.1 VasGene Therapeutics Inc Company Details
11.18.2 VasGene Therapeutics Inc Business Overview
11.18.3 VasGene Therapeutics Inc Gallbladder Cancer Treatment Introduction
11.18.4 VasGene Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021)
11.18.5 VasGene Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gallbladder Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Apatinib Mesylate
Table 3. Key Players of BGBA-317
Table 4. Key Players of Binimetinib
Table 5. Key Players of Others
Table 6. Global Gallbladder Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gallbladder Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gallbladder Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gallbladder Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Gallbladder Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gallbladder Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Gallbladder Cancer Treatment Market Trends
Table 13. Gallbladder Cancer Treatment Market Drivers
Table 14. Gallbladder Cancer Treatment Market Challenges
Table 15. Gallbladder Cancer Treatment Market Restraints
Table 16. Global Gallbladder Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gallbladder Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Gallbladder Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gallbladder Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Gallbladder Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gallbladder Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gallbladder Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Gallbladder Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gallbladder Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Gallbladder Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gallbladder Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gallbladder Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gallbladder Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Gallbladder Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gallbladder Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gallbladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gallbladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gallbladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gallbladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gallbladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gallbladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gallbladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gallbladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gallbladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gallbladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gallbladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gallbladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gallbladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gallbladder Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gallbladder Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gallbladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gallbladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gallbladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gallbladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gallbladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gallbladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gallbladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gallbladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gallbladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gallbladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gallbladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. 4SC AG Company Details
Table 64. 4SC AG Business Overview
Table 65. 4SC AG Gallbladder Cancer Treatment Product
Table 66. 4SC AG Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. 4SC AG Recent Development
Table 68. Advenchen Laboratories LLC Company Details
Table 69. Advenchen Laboratories LLC Business Overview
Table 70. Advenchen Laboratories LLC Gallbladder Cancer Treatment Product
Table 71. Advenchen Laboratories LLC Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Advenchen Laboratories LLC Recent Development
Table 73. Array BioPharma Inc Company Details
Table 74. Array BioPharma Inc Business Overview
Table 75. Array BioPharma Inc Gallbladder Cancer Treatment Product
Table 76. Array BioPharma Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Array BioPharma Inc Recent Development
Table 78. Aslan Pharmaceuticals Pte Ltd Company Details
Table 79. Aslan Pharmaceuticals Pte Ltd Business Overview
Table 80. Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Product
Table 81. Aslan Pharmaceuticals Pte Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Aslan Pharmaceuticals Pte Ltd Recent Development
Table 83. Bayer AG Company Details
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Gallbladder Cancer Treatment Product
Table 86. Bayer AG Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Bayer AG Recent Development
Table 88. BeiGene Ltd Company Details
Table 89. BeiGene Ltd Business Overview
Table 90. BeiGene Ltd Gallbladder Cancer Treatment Product
Table 91. BeiGene Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. BeiGene Ltd Recent Development
Table 93. Eli Lilly and Co Company Details
Table 94. Eli Lilly and Co Business Overview
Table 95. Eli Lilly and Co Gallbladder Cancer Treatment Product
Table 96. Eli Lilly and Co Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Eli Lilly and Co Recent Development
Table 98. Halozyme Therapeutics Inc Company Details
Table 99. Halozyme Therapeutics Inc Business Overview
Table 100. Halozyme Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Halozyme Therapeutics Inc Recent Development
Table 102. Hutchison MediPharma Ltd Company Details
Table 103. Hutchison MediPharma Ltd Business Overview
Table 104. Hutchison MediPharma Ltd Gallbladder Cancer Treatment Product
Table 105. Hutchison MediPharma Ltd Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 106. Hutchison MediPharma Ltd Recent Development
Table 107. Ipsen SA Company Details
Table 108. Ipsen SA Business Overview
Table 109. Ipsen SA Gallbladder Cancer Treatment Product
Table 110. Ipsen SA Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 111. Ipsen SA Recent Development
Table 112. Kringle Pharma Inc Company Details
Table 113. Kringle Pharma Inc Business Overview
Table 114. Kringle Pharma Inc Gallbladder Cancer Treatment Product
Table 115. Kringle Pharma Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 116. Kringle Pharma Inc Recent Development
Table 117. Leap Therapeutics Inc Company Details
Table 118. Leap Therapeutics Inc Business Overview
Table 119. Leap Therapeutics Inc Gallbladder Cancer Treatment Product
Table 120. Leap Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 121. Leap Therapeutics Inc Recent Development
Table 122. MedImmune LLC Company Details
Table 123. MedImmune LLC Business Overview
Table 124. MedImmune LLC Gallbladder Cancer Treatment Product
Table 125. MedImmune LLC Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 126. MedImmune LLC Recent Development
Table 127. Molecular Templates Inc Company Details
Table 128. Molecular Templates Inc Business Overview
Table 129. Molecular Templates Inc Gallbladder Cancer Treatment Product
Table 130. Molecular Templates Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 131. Molecular Templates Inc Recent Development
Table 132. Novartis AG Company Details
Table 133. Novartis AG Business Overview
Table 134. Novartis AG Gallbladder Cancer Treatment Product
Table 135. Novartis AG Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 136. Novartis AG Recent Development
Table 137. NuCana Plc Company Details
Table 138. NuCana Plc Business Overview
Table 139. NuCana Plc Gallbladder Cancer Treatment Product
Table 140. NuCana Plc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 141. NuCana Plc Recent Development
Table 142. OncoTherapy Science Inc Company Details
Table 143. OncoTherapy Science Inc Business Overview
Table 144. OncoTherapy Science Inc Gallbladder Cancer Treatment Product
Table 145. OncoTherapy Science Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 146. OncoTherapy Science Inc Recent Development
Table 147. VasGene Therapeutics Inc Company Details
Table 148. VasGene Therapeutics Inc Business Overview
Table 149. VasGene Therapeutics Inc Gallbladder Cancer Treatment Product
Table 150. VasGene Therapeutics Inc Revenue in Gallbladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 151. VasGene Therapeutics Inc Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gallbladder Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Apatinib Mesylate Features
Figure 3. BGBA-317 Features
Figure 4. Binimetinib Features
Figure 5. Others Features
Figure 6. Global Gallbladder Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Gallbladder Cancer Treatment Report Years Considered
Figure 11. Global Gallbladder Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gallbladder Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gallbladder Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Gallbladder Cancer Treatment Market Share by Regions (2022-2027)
Figure 15. Global Gallbladder Cancer Treatment Market Share by Players in 2020
Figure 16. Global Top Gallbladder Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gallbladder Cancer Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gallbladder Cancer Treatment Revenue in 2020
Figure 18. Global Gallbladder Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Gallbladder Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gallbladder Cancer Treatment Market Share by Type (2016-2027)
Figure 22. North America Gallbladder Cancer Treatment Market Share by Application (2016-2027)
Figure 23. North America Gallbladder Cancer Treatment Market Share by Country (2016-2027)
Figure 24. United States Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gallbladder Cancer Treatment Market Share by Type (2016-2027)
Figure 28. Europe Gallbladder Cancer Treatment Market Share by Application (2016-2027)
Figure 29. Europe Gallbladder Cancer Treatment Market Share by Country (2016-2027)
Figure 30. Germany Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gallbladder Cancer Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gallbladder Cancer Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gallbladder Cancer Treatment Market Share by Region (2016-2027)
Figure 40. China Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gallbladder Cancer Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Gallbladder Cancer Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Gallbladder Cancer Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gallbladder Cancer Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gallbladder Cancer Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gallbladder Cancer Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gallbladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. 4SC AG Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 60. Advenchen Laboratories LLC Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 61. Array BioPharma Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 62. Aslan Pharmaceuticals Pte Ltd Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 63. Bayer AG Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 64. BeiGene Ltd Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 65. Eli Lilly and Co Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 66. Halozyme Therapeutics Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 67. Hutchison MediPharma Ltd Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 68. Ipsen SA Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 69. Kringle Pharma Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 70. Leap Therapeutics Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 71. MedImmune LLC Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 72. Molecular Templates Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 73. Novartis AG Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 74. NuCana Plc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 75. OncoTherapy Science Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 76. VasGene Therapeutics Inc Revenue Growth Rate in Gallbladder Cancer Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---